Status:
UNKNOWN
Effect of Single Dose Antenatal Betamethasone on Neonatal Respiratory Morbidity After Elective Cesarean
Lead Sponsor:
Makassed General Hospital
Conditions:
Respiratory Morbidity
Eligibility:
FEMALE
17-45 years
Phase:
NA
Brief Summary
Patients undergoing elective C-section will be randomized into two groups. The first group will receive one dose of Betamethasone at least 24 hours before scheduled C-section. The second group will re...
Detailed Description
This is a prospective double blinded randomized clinical trial. Patients will be randomized into two groups. Group A will receive one dose of Betamethasone at least 24 hours before scheduled C-section...
Eligibility Criteria
Inclusion
- women with singleton or multiple gestation,
- between 37 and 40 weeks of pregnancy (as calculated from the first day of the last menstrual period)
Exclusion
- any medical problem that could affect fetal well-being;
- evidence of intrauterine infection,
- oligohydramnios,
- fetal congenital malformations,
- preeclampsia,
- maternal hypertension,
- severe fetal rhesus sensitization,
- antepartum hemorrhage,
- Intrauterine growth restriction
- preterm rupture of membranes
- preterm delivery
- previously received antenatal steroids less than one month ago
- those who decline to participate in the study.
Key Trial Info
Start Date :
May 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04407975
Start Date
May 29 2020
End Date
May 1 2021
Last Update
June 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Makassed General Hospital
Beirut, Lebanon